South Korean Retailer Olive Young Expands Post-Procedure Skincare Offerings

CJ Olive Young launched its Advanced Derma category in March 2026 with 21 products designed for post-procedure recovery, signaling a major retail push into clinical aftercare that medical-aesthetic practices should monitor. Driven in part by 1.31 million foreign dermatology patients visiting South Korea, the local dermacosmetics market is scaling rapidly. Dr.G's parent company saw sales grow from 155.5 billion KRW in 2020 to 232.8 billion KRW in 2025, while Olive Young's first-quarter 2026 dermacosmetics sales jumped 205 percent compared to 2020. Major Korean pharmaceutical companies are actively entering this retail space with medical-grade ingredients, including Pharma Research's PDRN-based Rejuvenex Cream and Dongkook Pharmaceutical's Centella-infused Expert Madeca Cream Active Renew PDRN. For practice owners, this shift highlights a growing patient demand for highly specialized, active-ingredient recovery protocols. To capture the margin that patients are increasingly willing to spend on post-treatment healing, consider auditing your current take-home retail inventory and introducing targeted PDRN or centella-based topicals immediately following energy-based or injectable treatments.

Source: Youth Daily, https://www.youthdaily.co.kr/news/article.html?no=150645